Home › Research › Topics › intravenous-immunoglobulin
intravenous-immunoglobulin
5 studies tagged intravenous-immunoglobulin, dated 2012-05-29 to 2015-10-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product 2015-10-28
- Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation 2015-01-06
- Clinical trials of intravenous immunoglobulin for Alzheimer's disease 2014-04-24
Studies
5 studies carry this tag.
Date range
2012 to 2015
Top journals
- Biochemistry 1
- International immunopharmacology 1
- Journal of clinical immunology 1
- Journal of neuroimmunology 1
- Journal of neuroinflammation 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The latest therapeutic approaches to Alzheimer disease are using intravenous immunoglobulin (IVIG) products.
-
Tau pathology, including neurofibrillary tangles, develops in Alzheimer's disease (AD).
-
The human polyclonal IgG antibody preparation known as Intravenous Immunoglobulin (IVIG) has been under study as a potential treatment for Alzheimer's disease (AD) since 2002.
-
40/100
Intravenous immunoglobulin (IVIG) products are prepared from plasma immunoglobulins from healthy donors.
-
Our data indicate limited ability of hIVIG to impact amyloid burden but shows changes in microglia, pro-inflammatory gene expression, and neurogenic effects.